Baidu
map
VIDEOSURGERY MINIINV 润色咨询

Videosurgery and Other Miniinvasive Techniques

出版年份：2006 年文章数：471 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：35.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2021-12-06 ms2000001976215004

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0
    经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2022-07-21 m414297222

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：微创外科
    经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-08-20 1de6dc0cm71(暂无匿称)

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：8月11号submit
    8月16号minor revise

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2021-12-28 rayms

    我们做研究时最常见或撰写的SCI文章类型是什么？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2021-12-28 rayms

    如何判断SCI文章类型？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1077215, encodeId=e29210e7215e9, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:800.0<br>经验分享：很好的期刊，虽然分低，但不是水刊，吊打medicine、oncology letter、ott、bmc surgery之类的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70d75432773, createdName=ms2000001976215004, createdTime=Mon Dec 06 03:42:06 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233925, encodeId=fa561233925c0, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：微创外科<br>经验分享：2022-4-28 submitt 2022-5-26 major revision 2022-6-16 resubmit 2022-7-21 received after minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Jul 21 23:14:03 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545700, encodeId=256a545e00ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：8月11号submit <br> 8月16号minor revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb471696214, createdName=1de6dc0cm71(暂无匿称), createdTime=Sun Aug 20 14:09:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103307, encodeId=3b53110330ed4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103308, encodeId=d806110330812, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543380, encodeId=4bc254338069, content=就这点分数,还跌,真对不起人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lv_xx, createdTime=Fri Jul 14 18:52:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-14 Lv_xx

    就这点分数,还跌,真对不起人

    0

共13条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map